| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.04 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |